| Trial ID: | L0033 |
| Source ID: | NCT05284656
|
| Associated Drug: |
Combination Of Pentoxifylline 400 Mg And Folic Acid
|
| Title: |
Effect of Folic Acid and/or Pentoxifylline on Patients With Chronic Kidney Disease
|
| Acronym: |
|
| Status: |
UNKNOWN
|
| Study Results: |
NO
|
| Results: |
|
| Conditions: |
Chronic Kidney Diseases
|
| Interventions: |
DRUG: combination of Pentoxifylline 400 MG and Folic Acid|DRUG: folic acid|DRUG: Pentoxifylline 400 MG
|
| Outcome Measures: |
Primary: Change in serum creatinine concentration, decrease in serum creatinine concentration in mg/dl from baseline, 6 months | Secondary: serum ferritin in ng/ml, increase in serum ferritin from baseline, 6 months|Protein /creatinine ratio, decrease in Protein /creatinine ratio, 6 months
|
| Sponsor/Collaborators: |
Sponsor: Al-Azhar University
|
| Gender: |
ALL
|
| Age: |
ADULT
|
| Phases: |
PHASE3
|
| Enrollment: |
80
|
| Study Type: |
INTERVENTIONAL
|
| Study Designs: |
Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: PREVENTION
|
| Start Date: |
2022-01-08
|
| Completion Date: |
2023-04
|
| Results First Posted: |
|
| Last Update Posted: |
2023-02-01
|
| Locations: |
Al Azhar University, Cairo, Egypt
|
| URL: |
https://clinicaltrials.gov/show/NCT05284656
|
